surmount-1 trial tirzepatide obesity without diabetes 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but diabetes. Researchers A 3-year study of tirzepatide

Research your destination's customs regulations well in advance through the Foreign, Commonwealth & Development Office (FCDO) website, which provides country-specific guidance on travelling with medications

This dual mechanism helps regulate blood sugar, reduce calorie intake, and promote significant weight reduction, making it a preferred option for patients needing metabolic improvements

Viral TikTok videos promote homemade beverages marketed as natural alternatives to Mounjaro, claiming rapid weight loss without a prescription

At Boca Medical Care, we understand that managing type 2 diabetes can be challenging

Today more and more women find that dealing with menopause symptoms is best accomplished via a combination of healthy lifestyle and alternative treatments